nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—PTGS2—atherosclerosis	0.154	0.529	CbGaD
Celecoxib—ALB—atherosclerosis	0.137	0.471	CbGaD
Celecoxib—ABCC4—Rosuvastatin—atherosclerosis	0.111	0.295	CbGbCtD
Celecoxib—ALB—Rosuvastatin—atherosclerosis	0.0411	0.109	CbGbCtD
Celecoxib—CYP2D6—Niacin—atherosclerosis	0.0238	0.0634	CbGbCtD
Celecoxib—CYP2C9—Rosuvastatin—atherosclerosis	0.0222	0.059	CbGbCtD
Celecoxib—CYP2C9—Simvastatin—atherosclerosis	0.0206	0.0548	CbGbCtD
Celecoxib—CYP2C9—Pravastatin—atherosclerosis	0.0202	0.0536	CbGbCtD
Celecoxib—CYP2C9—Lovastatin—atherosclerosis	0.0202	0.0536	CbGbCtD
Celecoxib—CYP2D6—Simvastatin—atherosclerosis	0.0188	0.0501	CbGbCtD
Celecoxib—CYP2D6—Lovastatin—atherosclerosis	0.0184	0.0491	CbGbCtD
Celecoxib—CYP2D6—Pravastatin—atherosclerosis	0.0184	0.0491	CbGbCtD
Celecoxib—CYP3A4—Ezetimibe—atherosclerosis	0.0129	0.0343	CbGbCtD
Celecoxib—CYP3A4—Rosuvastatin—atherosclerosis	0.0129	0.0343	CbGbCtD
Celecoxib—CYP3A4—Simvastatin—atherosclerosis	0.012	0.0319	CbGbCtD
Celecoxib—CYP3A4—Pravastatin—atherosclerosis	0.0117	0.0312	CbGbCtD
Celecoxib—CYP3A4—Lovastatin—atherosclerosis	0.0117	0.0312	CbGbCtD
Celecoxib—MAPK14—blood vessel—atherosclerosis	0.00194	0.0919	CbGeAlD
Celecoxib—PDPK1—adipose tissue—atherosclerosis	0.00142	0.0676	CbGeAlD
Celecoxib—PTGS2—leg—atherosclerosis	0.00131	0.062	CbGeAlD
Celecoxib—PTGS2—hindlimb—atherosclerosis	0.00117	0.0554	CbGeAlD
Celecoxib—PTGS2—appendage—atherosclerosis	0.001	0.0475	CbGeAlD
Celecoxib—PDPK1—liver—atherosclerosis	0.000998	0.0474	CbGeAlD
Celecoxib—MAPK14—connective tissue—atherosclerosis	0.000992	0.0471	CbGeAlD
Celecoxib—CA5A—liver—atherosclerosis	0.000937	0.0445	CbGeAlD
Celecoxib—MAPK14—cardiovascular system—atherosclerosis	0.000863	0.041	CbGeAlD
Celecoxib—MAPK14—adipose tissue—atherosclerosis	0.000761	0.0362	CbGeAlD
Celecoxib—CA12—connective tissue—atherosclerosis	0.000753	0.0358	CbGeAlD
Celecoxib—PTGS2—artery—atherosclerosis	0.000715	0.0339	CbGeAlD
Celecoxib—PTGS2—endothelium—atherosclerosis	0.000604	0.0287	CbGeAlD
Celecoxib—CA5B—cardiovascular system—atherosclerosis	0.000588	0.0279	CbGeAlD
Celecoxib—PTGS2—blood vessel—atherosclerosis	0.000557	0.0264	CbGeAlD
Celecoxib—MAPK14—liver—atherosclerosis	0.000534	0.0254	CbGeAlD
Celecoxib—CA14—liver—atherosclerosis	0.000519	0.0247	CbGeAlD
Celecoxib—CA5B—adipose tissue—atherosclerosis	0.000518	0.0246	CbGeAlD
Celecoxib—Etoricoxib—PTGS2—atherosclerosis	0.000456	1	CrCbGaD
Celecoxib—CA4—cardiovascular system—atherosclerosis	0.000406	0.0193	CbGeAlD
Celecoxib—ABCC4—adipose tissue—atherosclerosis	0.000389	0.0185	CbGeAlD
Celecoxib—CA2—connective tissue—atherosclerosis	0.000387	0.0184	CbGeAlD
Celecoxib—CA4—adipose tissue—atherosclerosis	0.000358	0.017	CbGeAlD
Celecoxib—CA2—cardiovascular system—atherosclerosis	0.000336	0.016	CbGeAlD
Celecoxib—ORM1—liver—atherosclerosis	0.000321	0.0153	CbGeAlD
Celecoxib—CA2—adipose tissue—atherosclerosis	0.000297	0.0141	CbGeAlD
Celecoxib—PTGS2—connective tissue—atherosclerosis	0.000285	0.0136	CbGeAlD
Celecoxib—CYP2C9—cardiovascular system—atherosclerosis	0.000285	0.0135	CbGeAlD
Celecoxib—ALB—liver—atherosclerosis	0.000282	0.0134	CbGeAlD
Celecoxib—ABCC4—liver—atherosclerosis	0.000273	0.013	CbGeAlD
Celecoxib—Flatulence—Ezetimibe—atherosclerosis	0.000249	0.00144	CcSEcCtD
Celecoxib—Pharyngitis—Pravastatin—atherosclerosis	0.000249	0.00143	CcSEcCtD
Celecoxib—PTGS2—cardiovascular system—atherosclerosis	0.000248	0.0118	CbGeAlD
Celecoxib—Muscle spasms—Lovastatin—atherosclerosis	0.000248	0.00143	CcSEcCtD
Celecoxib—Infection—Rosuvastatin—atherosclerosis	0.000247	0.00142	CcSEcCtD
Celecoxib—Alopecia—Simvastatin—atherosclerosis	0.000245	0.00141	CcSEcCtD
Celecoxib—Back pain—Ezetimibe—atherosclerosis	0.000245	0.00141	CcSEcCtD
Celecoxib—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000244	0.0014	CcSEcCtD
Celecoxib—Muscle spasms—Ezetimibe—atherosclerosis	0.000243	0.0014	CcSEcCtD
Celecoxib—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000243	0.0014	CcSEcCtD
Celecoxib—Vision blurred—Lovastatin—atherosclerosis	0.000243	0.0014	CcSEcCtD
Celecoxib—Mental disorder—Simvastatin—atherosclerosis	0.000243	0.0014	CcSEcCtD
Celecoxib—Eye disorder—Niacin—atherosclerosis	0.000238	0.00137	CcSEcCtD
Celecoxib—Flatulence—Simvastatin—atherosclerosis	0.000238	0.00137	CcSEcCtD
Celecoxib—Tinnitus—Niacin—atherosclerosis	0.000237	0.00137	CcSEcCtD
Celecoxib—Erythema multiforme—Pravastatin—atherosclerosis	0.000237	0.00137	CcSEcCtD
Celecoxib—Dysgeusia—Simvastatin—atherosclerosis	0.000236	0.00136	CcSEcCtD
Celecoxib—Flushing—Niacin—atherosclerosis	0.000236	0.00136	CcSEcCtD
Celecoxib—Angioedema—Lovastatin—atherosclerosis	0.000236	0.00136	CcSEcCtD
Celecoxib—Anaemia—Ezetimibe—atherosclerosis	0.000234	0.00135	CcSEcCtD
Celecoxib—Tinnitus—Pravastatin—atherosclerosis	0.000234	0.00135	CcSEcCtD
Celecoxib—Cardiac disorder—Pravastatin—atherosclerosis	0.000233	0.00134	CcSEcCtD
Celecoxib—Flushing—Pravastatin—atherosclerosis	0.000233	0.00134	CcSEcCtD
Celecoxib—Muscle spasms—Simvastatin—atherosclerosis	0.000232	0.00134	CcSEcCtD
Celecoxib—Vertigo—Lovastatin—atherosclerosis	0.000232	0.00134	CcSEcCtD
Celecoxib—Angioedema—Ezetimibe—atherosclerosis	0.000231	0.00133	CcSEcCtD
Celecoxib—Angiopathy—Niacin—atherosclerosis	0.000231	0.00133	CcSEcCtD
Celecoxib—Leukopenia—Lovastatin—atherosclerosis	0.000231	0.00133	CcSEcCtD
Celecoxib—Vision blurred—Simvastatin—atherosclerosis	0.000227	0.00131	CcSEcCtD
Celecoxib—Arrhythmia—Niacin—atherosclerosis	0.000227	0.00131	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000226	0.0013	CcSEcCtD
Celecoxib—Alopecia—Niacin—atherosclerosis	0.000225	0.0013	CcSEcCtD
Celecoxib—Insomnia—Rosuvastatin—atherosclerosis	0.000225	0.00129	CcSEcCtD
Celecoxib—Arrhythmia—Pravastatin—atherosclerosis	0.000224	0.00129	CcSEcCtD
Celecoxib—Palpitations—Ezetimibe—atherosclerosis	0.000224	0.00129	CcSEcCtD
Celecoxib—Paraesthesia—Rosuvastatin—atherosclerosis	0.000223	0.00129	CcSEcCtD
Celecoxib—Anaemia—Simvastatin—atherosclerosis	0.000223	0.00129	CcSEcCtD
Celecoxib—Alopecia—Pravastatin—atherosclerosis	0.000221	0.00128	CcSEcCtD
Celecoxib—Cough—Ezetimibe—atherosclerosis	0.000221	0.00127	CcSEcCtD
Celecoxib—Angioedema—Simvastatin—atherosclerosis	0.00022	0.00127	CcSEcCtD
Celecoxib—Arthralgia—Lovastatin—atherosclerosis	0.00022	0.00127	CcSEcCtD
Celecoxib—Chest pain—Lovastatin—atherosclerosis	0.00022	0.00127	CcSEcCtD
Celecoxib—Myalgia—Lovastatin—atherosclerosis	0.00022	0.00127	CcSEcCtD
Celecoxib—PTGS2—adipose tissue—atherosclerosis	0.000219	0.0104	CbGeAlD
Celecoxib—Anxiety—Lovastatin—atherosclerosis	0.000219	0.00126	CcSEcCtD
Celecoxib—Dyspepsia—Rosuvastatin—atherosclerosis	0.000219	0.00126	CcSEcCtD
Celecoxib—Hypertension—Ezetimibe—atherosclerosis	0.000218	0.00126	CcSEcCtD
Celecoxib—Flatulence—Niacin—atherosclerosis	0.000218	0.00126	CcSEcCtD
Celecoxib—Tension—Niacin—atherosclerosis	0.000217	0.00125	CcSEcCtD
Celecoxib—Vertigo—Simvastatin—atherosclerosis	0.000217	0.00125	CcSEcCtD
Celecoxib—Leukopenia—Simvastatin—atherosclerosis	0.000216	0.00124	CcSEcCtD
Celecoxib—Myalgia—Ezetimibe—atherosclerosis	0.000215	0.00124	CcSEcCtD
Celecoxib—Arthralgia—Ezetimibe—atherosclerosis	0.000215	0.00124	CcSEcCtD
Celecoxib—Chest pain—Ezetimibe—atherosclerosis	0.000215	0.00124	CcSEcCtD
Celecoxib—Nervousness—Niacin—atherosclerosis	0.000215	0.00124	CcSEcCtD
Celecoxib—Flatulence—Pravastatin—atherosclerosis	0.000215	0.00124	CcSEcCtD
Celecoxib—Dry mouth—Lovastatin—atherosclerosis	0.000215	0.00124	CcSEcCtD
Celecoxib—Tension—Pravastatin—atherosclerosis	0.000214	0.00123	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000214	0.00123	CcSEcCtD
Celecoxib—Dysgeusia—Pravastatin—atherosclerosis	0.000214	0.00123	CcSEcCtD
Celecoxib—Muscle spasms—Niacin—atherosclerosis	0.000213	0.00123	CcSEcCtD
Celecoxib—Constipation—Rosuvastatin—atherosclerosis	0.000212	0.00122	CcSEcCtD
Celecoxib—Confusional state—Lovastatin—atherosclerosis	0.000212	0.00122	CcSEcCtD
Celecoxib—Nervousness—Pravastatin—atherosclerosis	0.000212	0.00122	CcSEcCtD
Celecoxib—Dry mouth—Ezetimibe—atherosclerosis	0.000211	0.00121	CcSEcCtD
Celecoxib—Anaphylactic shock—Lovastatin—atherosclerosis	0.000211	0.00121	CcSEcCtD
Celecoxib—Muscle spasms—Pravastatin—atherosclerosis	0.00021	0.00121	CcSEcCtD
Celecoxib—Infection—Lovastatin—atherosclerosis	0.000209	0.00121	CcSEcCtD
Celecoxib—Vision blurred—Niacin—atherosclerosis	0.000209	0.0012	CcSEcCtD
Celecoxib—Confusional state—Ezetimibe—atherosclerosis	0.000208	0.0012	CcSEcCtD
Celecoxib—CA2—liver—atherosclerosis	0.000208	0.00988	CbGeAlD
Celecoxib—Anaphylactic shock—Ezetimibe—atherosclerosis	0.000206	0.00119	CcSEcCtD
Celecoxib—Thrombocytopenia—Lovastatin—atherosclerosis	0.000206	0.00119	CcSEcCtD
Celecoxib—Vision blurred—Pravastatin—atherosclerosis	0.000206	0.00118	CcSEcCtD
Celecoxib—Myalgia—Simvastatin—atherosclerosis	0.000205	0.00118	CcSEcCtD
Celecoxib—Chest pain—Simvastatin—atherosclerosis	0.000205	0.00118	CcSEcCtD
Celecoxib—Arthralgia—Simvastatin—atherosclerosis	0.000205	0.00118	CcSEcCtD
Celecoxib—Infection—Ezetimibe—atherosclerosis	0.000205	0.00118	CcSEcCtD
Celecoxib—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000205	0.00118	CcSEcCtD
Celecoxib—Anxiety—Simvastatin—atherosclerosis	0.000205	0.00118	CcSEcCtD
Celecoxib—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000203	0.00117	CcSEcCtD
Celecoxib—Nervous system disorder—Ezetimibe—atherosclerosis	0.000203	0.00117	CcSEcCtD
Celecoxib—Angioedema—Niacin—atherosclerosis	0.000202	0.00117	CcSEcCtD
Celecoxib—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000202	0.00117	CcSEcCtD
Celecoxib—Anaemia—Pravastatin—atherosclerosis	0.000202	0.00116	CcSEcCtD
Celecoxib—Anorexia—Lovastatin—atherosclerosis	0.000201	0.00116	CcSEcCtD
Celecoxib—Skin disorder—Ezetimibe—atherosclerosis	0.000201	0.00116	CcSEcCtD
Celecoxib—Angioedema—Pravastatin—atherosclerosis	0.000199	0.00115	CcSEcCtD
Celecoxib—Vertigo—Niacin—atherosclerosis	0.000199	0.00115	CcSEcCtD
Celecoxib—Syncope—Niacin—atherosclerosis	0.000199	0.00115	CcSEcCtD
Celecoxib—Confusional state—Simvastatin—atherosclerosis	0.000199	0.00114	CcSEcCtD
Celecoxib—Leukopenia—Niacin—atherosclerosis	0.000198	0.00114	CcSEcCtD
Celecoxib—Urticaria—Rosuvastatin—atherosclerosis	0.000197	0.00114	CcSEcCtD
Celecoxib—Oedema—Simvastatin—atherosclerosis	0.000197	0.00113	CcSEcCtD
Celecoxib—Anaphylactic shock—Simvastatin—atherosclerosis	0.000197	0.00113	CcSEcCtD
Celecoxib—Abdominal pain—Rosuvastatin—atherosclerosis	0.000196	0.00113	CcSEcCtD
Celecoxib—Vertigo—Pravastatin—atherosclerosis	0.000196	0.00113	CcSEcCtD
Celecoxib—Palpitations—Niacin—atherosclerosis	0.000196	0.00113	CcSEcCtD
Celecoxib—Infection—Simvastatin—atherosclerosis	0.000196	0.00113	CcSEcCtD
Celecoxib—Leukopenia—Pravastatin—atherosclerosis	0.000195	0.00113	CcSEcCtD
Celecoxib—Loss of consciousness—Niacin—atherosclerosis	0.000195	0.00112	CcSEcCtD
Celecoxib—Cough—Niacin—atherosclerosis	0.000193	0.00111	CcSEcCtD
Celecoxib—Thrombocytopenia—Simvastatin—atherosclerosis	0.000193	0.00111	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000192	0.00111	CcSEcCtD
Celecoxib—Insomnia—Lovastatin—atherosclerosis	0.00019	0.0011	CcSEcCtD
Celecoxib—Cough—Pravastatin—atherosclerosis	0.00019	0.0011	CcSEcCtD
Celecoxib—Paraesthesia—Lovastatin—atherosclerosis	0.000189	0.00109	CcSEcCtD
Celecoxib—Arthralgia—Niacin—atherosclerosis	0.000189	0.00109	CcSEcCtD
Celecoxib—Myalgia—Niacin—atherosclerosis	0.000189	0.00109	CcSEcCtD
Celecoxib—Hypertension—Pravastatin—atherosclerosis	0.000188	0.00109	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000188	0.00108	CcSEcCtD
Celecoxib—Anorexia—Simvastatin—atherosclerosis	0.000188	0.00108	CcSEcCtD
Celecoxib—Dyspnoea—Lovastatin—atherosclerosis	0.000188	0.00108	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000187	0.00108	CcSEcCtD
Celecoxib—Insomnia—Ezetimibe—atherosclerosis	0.000187	0.00108	CcSEcCtD
Celecoxib—Chest pain—Pravastatin—atherosclerosis	0.000186	0.00107	CcSEcCtD
Celecoxib—Arthralgia—Pravastatin—atherosclerosis	0.000186	0.00107	CcSEcCtD
Celecoxib—Myalgia—Pravastatin—atherosclerosis	0.000186	0.00107	CcSEcCtD
Celecoxib—Paraesthesia—Ezetimibe—atherosclerosis	0.000185	0.00107	CcSEcCtD
Celecoxib—Dyspepsia—Lovastatin—atherosclerosis	0.000185	0.00107	CcSEcCtD
Celecoxib—Anxiety—Pravastatin—atherosclerosis	0.000185	0.00107	CcSEcCtD
Celecoxib—Dry mouth—Niacin—atherosclerosis	0.000184	0.00106	CcSEcCtD
Celecoxib—Dyspnoea—Ezetimibe—atherosclerosis	0.000184	0.00106	CcSEcCtD
Celecoxib—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000183	0.00105	CcSEcCtD
Celecoxib—Decreased appetite—Lovastatin—atherosclerosis	0.000183	0.00105	CcSEcCtD
Celecoxib—Dyspepsia—Ezetimibe—atherosclerosis	0.000182	0.00105	CcSEcCtD
Celecoxib—Fatigue—Lovastatin—atherosclerosis	0.000182	0.00105	CcSEcCtD
Celecoxib—Oedema—Niacin—atherosclerosis	0.000181	0.00104	CcSEcCtD
Celecoxib—Anaphylactic shock—Niacin—atherosclerosis	0.000181	0.00104	CcSEcCtD
Celecoxib—Constipation—Lovastatin—atherosclerosis	0.00018	0.00104	CcSEcCtD
Celecoxib—Confusional state—Pravastatin—atherosclerosis	0.00018	0.00103	CcSEcCtD
Celecoxib—Decreased appetite—Ezetimibe—atherosclerosis	0.00018	0.00103	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000179	0.00103	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000178	0.00103	CcSEcCtD
Celecoxib—Asthenia—Rosuvastatin—atherosclerosis	0.000178	0.00103	CcSEcCtD
Celecoxib—Insomnia—Simvastatin—atherosclerosis	0.000178	0.00103	CcSEcCtD
Celecoxib—Anaphylactic shock—Pravastatin—atherosclerosis	0.000178	0.00103	CcSEcCtD
Celecoxib—Oedema—Pravastatin—atherosclerosis	0.000178	0.00103	CcSEcCtD
Celecoxib—Fatigue—Ezetimibe—atherosclerosis	0.000178	0.00103	CcSEcCtD
Celecoxib—Shock—Niacin—atherosclerosis	0.000178	0.00103	CcSEcCtD
Celecoxib—Infection—Pravastatin—atherosclerosis	0.000177	0.00102	CcSEcCtD
Celecoxib—Paraesthesia—Simvastatin—atherosclerosis	0.000177	0.00102	CcSEcCtD
Celecoxib—Constipation—Ezetimibe—atherosclerosis	0.000177	0.00102	CcSEcCtD
Celecoxib—Tachycardia—Niacin—atherosclerosis	0.000176	0.00102	CcSEcCtD
Celecoxib—CYP2C9—liver—atherosclerosis	0.000176	0.00836	CbGeAlD
Celecoxib—Pruritus—Rosuvastatin—atherosclerosis	0.000176	0.00101	CcSEcCtD
Celecoxib—Skin disorder—Niacin—atherosclerosis	0.000176	0.00101	CcSEcCtD
Celecoxib—Dyspnoea—Simvastatin—atherosclerosis	0.000176	0.00101	CcSEcCtD
Celecoxib—Hyperhidrosis—Niacin—atherosclerosis	0.000175	0.00101	CcSEcCtD
Celecoxib—Thrombocytopenia—Pravastatin—atherosclerosis	0.000174	0.001	CcSEcCtD
Celecoxib—Feeling abnormal—Lovastatin—atherosclerosis	0.000173	0.001	CcSEcCtD
Celecoxib—Dyspepsia—Simvastatin—atherosclerosis	0.000173	0.000999	CcSEcCtD
Celecoxib—Anorexia—Niacin—atherosclerosis	0.000172	0.000993	CcSEcCtD
Celecoxib—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000172	0.000992	CcSEcCtD
Celecoxib—Hyperhidrosis—Pravastatin—atherosclerosis	0.000172	0.000992	CcSEcCtD
Celecoxib—Decreased appetite—Simvastatin—atherosclerosis	0.000171	0.000987	CcSEcCtD
Celecoxib—Feeling abnormal—Ezetimibe—atherosclerosis	0.00017	0.000981	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.00017	0.00098	CcSEcCtD
Celecoxib—Diarrhoea—Rosuvastatin—atherosclerosis	0.00017	0.00098	CcSEcCtD
Celecoxib—Fatigue—Simvastatin—atherosclerosis	0.00017	0.000979	CcSEcCtD
Celecoxib—Anorexia—Pravastatin—atherosclerosis	0.00017	0.000978	CcSEcCtD
Celecoxib—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000169	0.000973	CcSEcCtD
Celecoxib—Constipation—Simvastatin—atherosclerosis	0.000168	0.000971	CcSEcCtD
Celecoxib—Urticaria—Lovastatin—atherosclerosis	0.000167	0.000964	CcSEcCtD
Celecoxib—Body temperature increased—Lovastatin—atherosclerosis	0.000166	0.000959	CcSEcCtD
Celecoxib—Abdominal pain—Lovastatin—atherosclerosis	0.000166	0.000959	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000165	0.000949	CcSEcCtD
Celecoxib—Dizziness—Rosuvastatin—atherosclerosis	0.000164	0.000947	CcSEcCtD
Celecoxib—Urticaria—Ezetimibe—atherosclerosis	0.000164	0.000945	CcSEcCtD
Celecoxib—Insomnia—Niacin—atherosclerosis	0.000164	0.000943	CcSEcCtD
Celecoxib—Body temperature increased—Ezetimibe—atherosclerosis	0.000163	0.000941	CcSEcCtD
Celecoxib—Abdominal pain—Ezetimibe—atherosclerosis	0.000163	0.000941	CcSEcCtD
Celecoxib—Paraesthesia—Niacin—atherosclerosis	0.000162	0.000936	CcSEcCtD
Celecoxib—Feeling abnormal—Simvastatin—atherosclerosis	0.000162	0.000935	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000162	0.000935	CcSEcCtD
Celecoxib—Dyspnoea—Niacin—atherosclerosis	0.000161	0.000929	CcSEcCtD
Celecoxib—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000161	0.000928	CcSEcCtD
Celecoxib—Insomnia—Pravastatin—atherosclerosis	0.000161	0.000928	CcSEcCtD
Celecoxib—Somnolence—Niacin—atherosclerosis	0.000161	0.000926	CcSEcCtD
Celecoxib—Paraesthesia—Pravastatin—atherosclerosis	0.00016	0.000921	CcSEcCtD
Celecoxib—Dyspepsia—Niacin—atherosclerosis	0.000159	0.000917	CcSEcCtD
Celecoxib—Dyspnoea—Pravastatin—atherosclerosis	0.000159	0.000915	CcSEcCtD
Celecoxib—Decreased appetite—Niacin—atherosclerosis	0.000157	0.000906	CcSEcCtD
Celecoxib—Dyspepsia—Pravastatin—atherosclerosis	0.000157	0.000903	CcSEcCtD
Celecoxib—Rash—Rosuvastatin—atherosclerosis	0.000157	0.000903	CcSEcCtD
Celecoxib—Dermatitis—Rosuvastatin—atherosclerosis	0.000156	0.000902	CcSEcCtD
Celecoxib—Urticaria—Simvastatin—atherosclerosis	0.000156	0.000902	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Niacin—atherosclerosis	0.000156	0.0009	CcSEcCtD
Celecoxib—Body temperature increased—Simvastatin—atherosclerosis	0.000156	0.000897	CcSEcCtD
Celecoxib—Abdominal pain—Simvastatin—atherosclerosis	0.000156	0.000897	CcSEcCtD
Celecoxib—Headache—Rosuvastatin—atherosclerosis	0.000156	0.000897	CcSEcCtD
Celecoxib—Hypersensitivity—Lovastatin—atherosclerosis	0.000155	0.000894	CcSEcCtD
Celecoxib—Decreased appetite—Pravastatin—atherosclerosis	0.000155	0.000892	CcSEcCtD
Celecoxib—PTGS2—liver—atherosclerosis	0.000154	0.00729	CbGeAlD
Celecoxib—Fatigue—Pravastatin—atherosclerosis	0.000153	0.000885	CcSEcCtD
Celecoxib—Constipation—Pravastatin—atherosclerosis	0.000152	0.000877	CcSEcCtD
Celecoxib—Hypersensitivity—Ezetimibe—atherosclerosis	0.000152	0.000877	CcSEcCtD
Celecoxib—Asthenia—Lovastatin—atherosclerosis	0.000151	0.000871	CcSEcCtD
Celecoxib—Pruritus—Lovastatin—atherosclerosis	0.000149	0.000858	CcSEcCtD
Celecoxib—Asthenia—Ezetimibe—atherosclerosis	0.000148	0.000854	CcSEcCtD
Celecoxib—Gastrointestinal pain—Niacin—atherosclerosis	0.000148	0.000852	CcSEcCtD
Celecoxib—Nausea—Rosuvastatin—atherosclerosis	0.000148	0.00085	CcSEcCtD
Celecoxib—Feeling abnormal—Pravastatin—atherosclerosis	0.000147	0.000846	CcSEcCtD
Celecoxib—Pruritus—Ezetimibe—atherosclerosis	0.000146	0.000842	CcSEcCtD
Celecoxib—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000146	0.000839	CcSEcCtD
Celecoxib—Hypersensitivity—Simvastatin—atherosclerosis	0.000145	0.000836	CcSEcCtD
Celecoxib—Diarrhoea—Lovastatin—atherosclerosis	0.000144	0.00083	CcSEcCtD
Celecoxib—Urticaria—Niacin—atherosclerosis	0.000144	0.000828	CcSEcCtD
Celecoxib—Abdominal pain—Niacin—atherosclerosis	0.000143	0.000824	CcSEcCtD
Celecoxib—Body temperature increased—Niacin—atherosclerosis	0.000143	0.000824	CcSEcCtD
Celecoxib—Urticaria—Pravastatin—atherosclerosis	0.000141	0.000815	CcSEcCtD
Celecoxib—Asthenia—Simvastatin—atherosclerosis	0.000141	0.000814	CcSEcCtD
Celecoxib—Diarrhoea—Ezetimibe—atherosclerosis	0.000141	0.000814	CcSEcCtD
Celecoxib—Abdominal pain—Pravastatin—atherosclerosis	0.000141	0.000811	CcSEcCtD
Celecoxib—Body temperature increased—Pravastatin—atherosclerosis	0.000141	0.000811	CcSEcCtD
Celecoxib—Pruritus—Simvastatin—atherosclerosis	0.000139	0.000803	CcSEcCtD
Celecoxib—Dizziness—Lovastatin—atherosclerosis	0.000139	0.000802	CcSEcCtD
Celecoxib—Dizziness—Ezetimibe—atherosclerosis	0.000137	0.000787	CcSEcCtD
Celecoxib—Diarrhoea—Simvastatin—atherosclerosis	0.000135	0.000777	CcSEcCtD
Celecoxib—CYP3A4—liver—atherosclerosis	0.000134	0.00637	CbGeAlD
Celecoxib—Vomiting—Lovastatin—atherosclerosis	0.000134	0.000771	CcSEcCtD
Celecoxib—Hypersensitivity—Niacin—atherosclerosis	0.000133	0.000768	CcSEcCtD
Celecoxib—Rash—Lovastatin—atherosclerosis	0.000133	0.000765	CcSEcCtD
Celecoxib—Dermatitis—Lovastatin—atherosclerosis	0.000133	0.000764	CcSEcCtD
Celecoxib—CYP2D6—liver—atherosclerosis	0.000132	0.00627	CbGeAlD
Celecoxib—Headache—Lovastatin—atherosclerosis	0.000132	0.00076	CcSEcCtD
Celecoxib—Vomiting—Ezetimibe—atherosclerosis	0.000131	0.000757	CcSEcCtD
Celecoxib—Hypersensitivity—Pravastatin—atherosclerosis	0.000131	0.000756	CcSEcCtD
Celecoxib—Dizziness—Simvastatin—atherosclerosis	0.00013	0.000751	CcSEcCtD
Celecoxib—Rash—Ezetimibe—atherosclerosis	0.00013	0.00075	CcSEcCtD
Celecoxib—Dermatitis—Ezetimibe—atherosclerosis	0.00013	0.00075	CcSEcCtD
Celecoxib—Asthenia—Niacin—atherosclerosis	0.00013	0.000748	CcSEcCtD
Celecoxib—Headache—Ezetimibe—atherosclerosis	0.000129	0.000746	CcSEcCtD
Celecoxib—Pruritus—Niacin—atherosclerosis	0.000128	0.000737	CcSEcCtD
Celecoxib—Asthenia—Pravastatin—atherosclerosis	0.000128	0.000736	CcSEcCtD
Celecoxib—Pruritus—Pravastatin—atherosclerosis	0.000126	0.000726	CcSEcCtD
Celecoxib—Vomiting—Simvastatin—atherosclerosis	0.000125	0.000722	CcSEcCtD
Celecoxib—Nausea—Lovastatin—atherosclerosis	0.000125	0.000721	CcSEcCtD
Celecoxib—Rash—Simvastatin—atherosclerosis	0.000124	0.000716	CcSEcCtD
Celecoxib—Dermatitis—Simvastatin—atherosclerosis	0.000124	0.000715	CcSEcCtD
Celecoxib—Diarrhoea—Niacin—atherosclerosis	0.000124	0.000713	CcSEcCtD
Celecoxib—Headache—Simvastatin—atherosclerosis	0.000123	0.000711	CcSEcCtD
Celecoxib—Nausea—Ezetimibe—atherosclerosis	0.000123	0.000707	CcSEcCtD
Celecoxib—Diarrhoea—Pravastatin—atherosclerosis	0.000122	0.000702	CcSEcCtD
Celecoxib—Dizziness—Niacin—atherosclerosis	0.00012	0.000689	CcSEcCtD
Celecoxib—Dizziness—Pravastatin—atherosclerosis	0.000118	0.000679	CcSEcCtD
Celecoxib—Nausea—Simvastatin—atherosclerosis	0.000117	0.000674	CcSEcCtD
Celecoxib—Vomiting—Niacin—atherosclerosis	0.000115	0.000663	CcSEcCtD
Celecoxib—Rash—Niacin—atherosclerosis	0.000114	0.000657	CcSEcCtD
Celecoxib—Dermatitis—Niacin—atherosclerosis	0.000114	0.000656	CcSEcCtD
Celecoxib—Headache—Niacin—atherosclerosis	0.000113	0.000653	CcSEcCtD
Celecoxib—Vomiting—Pravastatin—atherosclerosis	0.000113	0.000652	CcSEcCtD
Celecoxib—Rash—Pravastatin—atherosclerosis	0.000112	0.000647	CcSEcCtD
Celecoxib—Dermatitis—Pravastatin—atherosclerosis	0.000112	0.000646	CcSEcCtD
Celecoxib—Headache—Pravastatin—atherosclerosis	0.000112	0.000643	CcSEcCtD
Celecoxib—Nausea—Niacin—atherosclerosis	0.000107	0.000619	CcSEcCtD
Celecoxib—Nausea—Pravastatin—atherosclerosis	0.000106	0.000609	CcSEcCtD
Celecoxib—MAPK14—Signaling Pathways—CCL5—atherosclerosis	6.66e-06	4.83e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—BGN—atherosclerosis	6.64e-06	4.81e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NAMPT—atherosclerosis	6.64e-06	4.81e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—IL6—atherosclerosis	6.64e-06	4.81e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	6.6e-06	4.78e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—LIPC—atherosclerosis	6.6e-06	4.78e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—SERPINE1—atherosclerosis	6.59e-06	4.77e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—BGN—atherosclerosis	6.59e-06	4.77e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOA5—atherosclerosis	6.58e-06	4.76e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOC3—atherosclerosis	6.56e-06	4.75e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	6.54e-06	4.74e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—SERPINE1—atherosclerosis	6.53e-06	4.73e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOA5—atherosclerosis	6.52e-06	4.72e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—LDLR—atherosclerosis	6.52e-06	4.72e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LPL—atherosclerosis	6.52e-06	4.72e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CETP—atherosclerosis	6.37e-06	4.61e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ABCA1—atherosclerosis	6.34e-06	4.6e-05	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—AKT1—atherosclerosis	6.34e-06	4.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PRKCG—atherosclerosis	6.34e-06	4.59e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	6.33e-06	4.59e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PLA2G1B—atherosclerosis	6.33e-06	4.59e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MMP9—atherosclerosis	6.32e-06	4.58e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	6.28e-06	4.55e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NFKB1—atherosclerosis	6.25e-06	4.53e-05	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—AKT1—atherosclerosis	6.24e-06	4.52e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—NOS3—atherosclerosis	6.24e-06	4.52e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOB—atherosclerosis	6.23e-06	4.51e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	6.2e-06	4.49e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SPP1—atherosclerosis	6.17e-06	4.47e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	6.15e-06	4.45e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAPK8—atherosclerosis	6.14e-06	4.45e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	6.13e-06	4.44e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—IL6—atherosclerosis	6.13e-06	4.44e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—AKT1—atherosclerosis	6.13e-06	4.44e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALOX5—atherosclerosis	6.11e-06	4.43e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—SCARB1—atherosclerosis	6.1e-06	4.42e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—IL6—atherosclerosis	6.07e-06	4.4e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALOX5—atherosclerosis	6.06e-06	4.39e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IFNG—atherosclerosis	6.04e-06	4.37e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—LPL—atherosclerosis	5.94e-06	4.31e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCG1—atherosclerosis	5.92e-06	4.29e-05	CbGpPWpGaD
Celecoxib—CA12—Metabolism—AKT1—atherosclerosis	5.79e-06	4.19e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PRKCG—atherosclerosis	5.78e-06	4.19e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HMGCR—atherosclerosis	5.76e-06	4.17e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PDGFB—atherosclerosis	5.71e-06	4.14e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VEGFA—atherosclerosis	5.67e-06	4.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—AKT1—atherosclerosis	5.66e-06	4.1e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—STAT3—atherosclerosis	5.62e-06	4.07e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—IL6—atherosclerosis	5.6e-06	4.06e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	5.6e-06	4.06e-05	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—AKT1—atherosclerosis	5.6e-06	4.06e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AGT—atherosclerosis	5.57e-06	4.04e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—FABP4—atherosclerosis	5.56e-06	4.03e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LCAT—atherosclerosis	5.56e-06	4.03e-05	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	5.56e-06	4.03e-05	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—AKT1—atherosclerosis	5.55e-06	4.02e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NAMPT—atherosclerosis	5.48e-06	3.97e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—LEP—atherosclerosis	5.46e-06	3.96e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOE—atherosclerosis	5.46e-06	3.96e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOA4—atherosclerosis	5.46e-06	3.96e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—LIPC—atherosclerosis	5.45e-06	3.95e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—HMOX1—atherosclerosis	5.44e-06	3.94e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NAMPT—atherosclerosis	5.44e-06	3.94e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOC3—atherosclerosis	5.42e-06	3.92e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—IL6—atherosclerosis	5.41e-06	3.92e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CAV1—atherosclerosis	5.41e-06	3.92e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	5.4e-06	3.91e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LIPC—atherosclerosis	5.4e-06	3.91e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—APOA1—atherosclerosis	5.4e-06	3.91e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL1B—atherosclerosis	5.39e-06	3.9e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—LDLR—atherosclerosis	5.38e-06	3.9e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOC3—atherosclerosis	5.37e-06	3.89e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—MAPK3—atherosclerosis	5.37e-06	3.89e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP7A1—atherosclerosis	5.37e-06	3.89e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MTHFR—atherosclerosis	5.35e-06	3.88e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LDLR—atherosclerosis	5.34e-06	3.87e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CETP—atherosclerosis	5.26e-06	3.81e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—ESR1—atherosclerosis	5.21e-06	3.78e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOB—atherosclerosis	5.21e-06	3.78e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CETP—atherosclerosis	5.21e-06	3.78e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—PDGFB—atherosclerosis	5.21e-06	3.77e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—atherosclerosis	5.21e-06	3.77e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	5.19e-06	3.76e-05	CbGpPWpGaD
Celecoxib—PDPK1—Disease—AKT1—atherosclerosis	5.17e-06	3.74e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—F2—atherosclerosis	5.15e-06	3.73e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—ABCA1—atherosclerosis	5.13e-06	3.72e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GSTM1—atherosclerosis	5.07e-06	3.67e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—SCARB1—atherosclerosis	5.03e-06	3.65e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NFKB1—atherosclerosis	5.02e-06	3.64e-05	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—AKT1—atherosclerosis	4.99e-06	3.62e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—SCARB1—atherosclerosis	4.99e-06	3.62e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOE—atherosclerosis	4.98e-06	3.61e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—LPL—atherosclerosis	4.98e-06	3.61e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CYP27A1—atherosclerosis	4.96e-06	3.59e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK8—atherosclerosis	4.94e-06	3.58e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CAV1—atherosclerosis	4.94e-06	3.58e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—PIK3CG—atherosclerosis	4.93e-06	3.57e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—APOA1—atherosclerosis	4.93e-06	3.57e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.86e-06	3.52e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—GPX1—atherosclerosis	4.86e-06	3.52e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMGCR—atherosclerosis	4.75e-06	3.44e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CD36—atherosclerosis	4.73e-06	3.43e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMGCR—atherosclerosis	4.71e-06	3.41e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	4.7e-06	3.41e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALOX15—atherosclerosis	4.7e-06	3.41e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	4.7e-06	3.41e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOA2—atherosclerosis	4.7e-06	3.41e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—INS—atherosclerosis	4.67e-06	3.38e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCG5—atherosclerosis	4.64e-06	3.36e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS2—atherosclerosis	4.64e-06	3.36e-05	CbGpPWpGaD
Celecoxib—CA4—Metabolism—AKT1—atherosclerosis	4.61e-06	3.34e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL2—atherosclerosis	4.59e-06	3.33e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—STAT3—atherosclerosis	4.51e-06	3.27e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IGF1—atherosclerosis	4.51e-06	3.27e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—VEGFA—atherosclerosis	4.49e-06	3.26e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LPA—atherosclerosis	4.48e-06	3.25e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—MTHFR—atherosclerosis	4.48e-06	3.25e-05	CbGpPWpGaD
Celecoxib—CA2—Metabolism—AKT1—atherosclerosis	4.42e-06	3.2e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—HMOX1—atherosclerosis	4.4e-06	3.19e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARA—atherosclerosis	4.4e-06	3.19e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—BGN—atherosclerosis	4.34e-06	3.15e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—MAPK3—atherosclerosis	4.31e-06	3.12e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOA5—atherosclerosis	4.3e-06	3.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—MAPK3—atherosclerosis	4.29e-06	3.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SERPINE1—atherosclerosis	4.29e-06	3.1e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AGT—atherosclerosis	4.26e-06	3.08e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—INS—atherosclerosis	4.26e-06	3.08e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	4.25e-06	3.08e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—MAPK3—atherosclerosis	4.25e-06	3.08e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ABCA1—atherosclerosis	4.24e-06	3.07e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOB—atherosclerosis	4.22e-06	3.06e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ABCA1—atherosclerosis	4.2e-06	3.04e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOE—atherosclerosis	4.17e-06	3.02e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	4.14e-06	3e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—CAV1—atherosclerosis	4.13e-06	2.99e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—APOA1—atherosclerosis	4.13e-06	2.99e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—atherosclerosis	4.12e-06	2.99e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GSTM1—atherosclerosis	4.1e-06	2.97e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NOS3—atherosclerosis	4.09e-06	2.96e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—LPL—atherosclerosis	4.03e-06	2.92e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALOX5—atherosclerosis	4e-06	2.9e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—GPX1—atherosclerosis	3.93e-06	2.85e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—IL6—atherosclerosis	3.92e-06	2.84e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SERPINE1—atherosclerosis	3.91e-06	2.83e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CD36—atherosclerosis	3.83e-06	2.77e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PIK3CG—atherosclerosis	3.77e-06	2.73e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NOS3—atherosclerosis	3.73e-06	2.7e-05	CbGpPWpGaD
Celecoxib—CA9—Metabolism—AKT1—atherosclerosis	3.73e-06	2.7e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—HMOX1—atherosclerosis	3.64e-06	2.63e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—PPARG—atherosclerosis	3.63e-06	2.63e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CXCL8—atherosclerosis	3.63e-06	2.63e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—MTHFR—atherosclerosis	3.63e-06	2.63e-05	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—AKT1—atherosclerosis	3.62e-06	2.62e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—HMOX1—atherosclerosis	3.6e-06	2.61e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.59e-06	2.6e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—INS—atherosclerosis	3.56e-06	2.58e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LIPC—atherosclerosis	3.56e-06	2.58e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARA—atherosclerosis	3.56e-06	2.58e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOC3—atherosclerosis	3.54e-06	2.56e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LDLR—atherosclerosis	3.52e-06	2.55e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOB—atherosclerosis	3.48e-06	2.52e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOB—atherosclerosis	3.45e-06	2.5e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AGT—atherosclerosis	3.45e-06	2.5e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CETP—atherosclerosis	3.44e-06	2.49e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GSTM1—atherosclerosis	3.39e-06	2.45e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOE—atherosclerosis	3.38e-06	2.45e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GSTM1—atherosclerosis	3.36e-06	2.43e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—CAV1—atherosclerosis	3.34e-06	2.42e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—APOA1—atherosclerosis	3.34e-06	2.42e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—LPL—atherosclerosis	3.33e-06	2.41e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—LPL—atherosclerosis	3.3e-06	2.39e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.29e-06	2.38e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MMP9—atherosclerosis	3.28e-06	2.38e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—ALB—atherosclerosis	3.27e-06	2.37e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NFKB1—atherosclerosis	3.25e-06	2.35e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—GPX1—atherosclerosis	3.24e-06	2.35e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—GPX1—atherosclerosis	3.22e-06	2.33e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK8—atherosclerosis	3.19e-06	2.31e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CD36—atherosclerosis	3.16e-06	2.29e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL6—atherosclerosis	3.15e-06	2.28e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CD36—atherosclerosis	3.13e-06	2.27e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NOS3—atherosclerosis	3.13e-06	2.26e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMGCR—atherosclerosis	3.11e-06	2.25e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PIK3CG—atherosclerosis	3.05e-06	2.21e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—MTHFR—atherosclerosis	2.99e-06	2.17e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—MTHFR—atherosclerosis	2.97e-06	2.15e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VEGFA—atherosclerosis	2.95e-06	2.14e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PPARG—atherosclerosis	2.94e-06	2.13e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARA—atherosclerosis	2.94e-06	2.13e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—STAT3—atherosclerosis	2.92e-06	2.11e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARA—atherosclerosis	2.91e-06	2.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—AKT1—atherosclerosis	2.91e-06	2.11e-05	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—AKT1—atherosclerosis	2.89e-06	2.1e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—INS—atherosclerosis	2.88e-06	2.09e-05	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—AKT1—atherosclerosis	2.87e-06	2.08e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AGT—atherosclerosis	2.84e-06	2.06e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AGT—atherosclerosis	2.82e-06	2.04e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—MAPK3—atherosclerosis	2.79e-06	2.02e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOE—atherosclerosis	2.79e-06	2.02e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.77e-06	2.01e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOE—atherosclerosis	2.76e-06	2e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—CAV1—atherosclerosis	2.76e-06	2e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—APOA1—atherosclerosis	2.76e-06	2e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—CAV1—atherosclerosis	2.74e-06	1.98e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—APOA1—atherosclerosis	2.73e-06	1.98e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—atherosclerosis	2.71e-06	1.96e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—STAT3—atherosclerosis	2.66e-06	1.93e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—MAPK3—atherosclerosis	2.54e-06	1.84e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NOS3—atherosclerosis	2.53e-06	1.83e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PIK3CG—atherosclerosis	2.52e-06	1.82e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PIK3CG—atherosclerosis	2.49e-06	1.81e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—atherosclerosis	2.47e-06	1.79e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PPARG—atherosclerosis	2.43e-06	1.76e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PPARG—atherosclerosis	2.41e-06	1.74e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—INS—atherosclerosis	2.38e-06	1.72e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.38e-06	1.72e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—INS—atherosclerosis	2.36e-06	1.71e-05	CbGpPWpGaD
Celecoxib—ALB—Metabolism—PTGS2—atherosclerosis	2.31e-06	1.68e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOB—atherosclerosis	2.28e-06	1.65e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.22e-06	1.6e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—ALB—atherosclerosis	2.18e-06	1.58e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—LPL—atherosclerosis	2.17e-06	1.57e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—ALB—atherosclerosis	2.16e-06	1.57e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—GPX1—atherosclerosis	2.12e-06	1.54e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NOS3—atherosclerosis	2.09e-06	1.51e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NOS3—atherosclerosis	2.07e-06	1.5e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CD36—atherosclerosis	2.07e-06	1.5e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL6—atherosclerosis	2.04e-06	1.48e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.96e-06	1.42e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARA—atherosclerosis	1.92e-06	1.39e-05	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—PTGS2—atherosclerosis	1.91e-06	1.38e-05	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.89e-06	1.37e-05	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—AKT1—atherosclerosis	1.88e-06	1.36e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AGT—atherosclerosis	1.86e-06	1.35e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—IL6—atherosclerosis	1.86e-06	1.35e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOE—atherosclerosis	1.82e-06	1.32e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—CAV1—atherosclerosis	1.81e-06	1.31e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—APOA1—atherosclerosis	1.8e-06	1.3e-05	CbGpPWpGaD
Celecoxib—PTGS2—Disease—AKT1—atherosclerosis	1.72e-06	1.24e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.64e-06	1.19e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PPARG—atherosclerosis	1.59e-06	1.15e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—INS—atherosclerosis	1.56e-06	1.13e-05	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—AKT1—atherosclerosis	1.44e-06	1.04e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—ALB—atherosclerosis	1.43e-06	1.03e-05	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NOS3—atherosclerosis	1.37e-06	9.89e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.25e-06	9.05e-06	CbGpPWpGaD
Celecoxib—ALB—Metabolism—AKT1—atherosclerosis	1.16e-06	8.42e-06	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—AKT1—atherosclerosis	9.6e-07	6.95e-06	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—AKT1—atherosclerosis	9.52e-07	6.89e-06	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—AKT1—atherosclerosis	6.28e-07	4.55e-06	CbGpPWpGaD
